Immunophenotyping of peripheral blood mononuclear cells and intracellular detection of IL-2, IFNγ and IL-4 by flow cytometry in patients with actinomycetoma by Nocardia brasiliensis and Actinomadura madurae. Findings in six patients

Heuze de Icaza Yvonne, Castrillón Rivera Laura Estela, Garibay-Escobar Adriana, Santos-Argumedo Leopoldo, Sandoval Trujillo Horacio, Padilla Desgarennes Carmen, Palma Ramos Alejandro

.

DOI: 10.4236/health.2011.33033                

Abstract

Mycetoma is a chronic, granulomatous, progressive inflammatory disease; it usually involves the subcutaneous tissue after a traumatic inoculation of the causative organism. Mycetoma may be caused by true fungi or bacteria (actinomycetes) and hence it is classified as eumycetoma and actinomycetoma respectively. Mycetoma immunological studies have fre- quently addressed humoral aspects. Few reports have addressed the role of cellular immunity in humans, for this reason, we were interested in finding differences in the circulating population of mononuclear cells or in the ability of this pathology to produce cytokines after mitogen stimulation. In this study, immunophenotyping of peripheral blood mononuclear cells (PBMN) and intracellular detection by flow cytometry of IL-2, IFNγ and IL-4 in patients with actino- mycetoma by Nocardia brasiliensis and Actino- madura madurae were evaluated. We investi- gated the expression of T-cells (CD3, CD4 and CD8), B-cells (CD19), monocytes (CD14), and natural killer cells (CD16 and CD56) markers. CD69 and CD25 were used to monitor individual activated cell subsets. The percentage values of the cells were calculated. Our results indicated that PBMC from patients with mycetoma show similar percentages of circulating cells when compared with healthy donors. The expression of IL-2 receptor (IL-2R) by mitogen activation was similar in these two groups. These findings suggest that circulating lymphocytes are not affected by this pathology. Intracellular IL-4 was increased only in patients with mycetoma by N. brasiliensis, suggesting a TH2 profile; this ob- servation has been reported by other authors.

Keywords

Actinomycetoma; Nocardia brasiliensis; Actinomadura madurae; Cytokines; CD4+; CD8+; CD56+

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Welsh, O., Vera-Cabrera, L. and Mejía, M.A. (2007) Aspectos clínicos, radiológicos y terapéuticos del actinomicetoma. In: En Serrano, J.A., Sandoval, H. and Beaman, B.L., Eds., Actinomicetoma. Plaza y Valdés, México DF.
[2]	Castrillón, R.L., Palma, R.A. and Sampedro, P.J.G. (1998) Actinomicetoma. Bioquimia.
[3]	Mahgoub, E.S. and Murray, I.G. (1973) Mycetoma. Medical Books Ltd., William Heinemann, London.
[4]	Maga?a, M. (1984) Mycetoma. International Journal of Dermatology, 23, 221-236. doi:10.1111/j.1365-4362.1984.tb01238.x
[5]	EL Hag, I.A., Fahal, A.H. and Khalil, E.A.G. (1996) Fine needle aspiration cytology of mycetoma. Acta Cytologica, 40, 461-464.
[6]	Fahal, A.H., El Toum, E.A., Gumaa, S.A., Mahgoub, E.S. and El-Hassan, A.M. (1995) Host tissue reaction to Madurella mycetomatis: New classification. Journal of Medical and Veterinary Mycology, 33, 103-106. doi:10.1080/02681219580000041
[7]	Fahal, A.H. (2004) Mycetoma: A thorn in the flesh. Transactions of the Royal Society of Tropical Medicine and Hygiene, 98, 3-11. doi:10.1016/S0035-9203(03)00009-9
[8]	Palma-Ramos, A, Castrillón-Rivera, L.E., Piza?a-Cure?o, A., Vega-Memije, M.E., López-Bárcenas, A.P., Arenas-Guzmán, R. and Padilla-Desgarennes, M.C. (2007) Subpoblaciones de linfocitos T en el micetoma. Dermatología Rev Mex, 51, 212-218.
[9]	Cenci, G.C., Castro, M.L.G. and Sotto, N.M. (2003) Lymphocyte subsets, macrophages and Langerhans cells in actinomycetoma and eumycetoma tissue reaction. Acta Tropica, 87, 377-384. doi:10.1016/S0001-706X(03)00139-6
[10]	Humpreys, D.W., Crowder, J.G. and White, A. (1975) Serological reactions to Nocardia antigens. American Journal of Science, 269, 323-336.
[11]	Salinas-Carmona, M.C. (2001) Anticuerpos anti-Nocardia brasiliensis en pacientes con actinomicetoma y su utilidad clínica. Gac Med Mex, 137, 1-8.
[12]	Salinas-Carmona, M.C. and Pérez-Rivera, I. (2004) Humoral Immunity through IgM protects mice from an experimental mycetoma infection by Nocardia brasiliensis. Infection and Immunity, 72, 5597-5604. doi:10.1128/IAI.72.10.5597-5604.2004
[13]	Araujo, M.J. and Castaneda, E. (1997) Madurella mycetomatis for the serodiagnosis of mycetoma. Revista Iberoamericana de Micología, 14, 31-35.
[14]	Ortíz-Ortíz, L. and Bojalil, L.F. (1972) Delayed skin reactions to cytoplasmic estracts of Nocardia organisms as a means of diagnosis and epidemiological study of Nocardia infections. Clinical & Experimental Immunology, 12, 225-229.
[15]	Sundararag, T. and Agarwal, S.C. (1977) Cell-mediated immunity in experimental Nocardia asteroides infection. Infection and Immunity, 15, 370-375.
[16]	Mahgoub, E.S., Gumaa, D.A. and El Hassan, A.M. (1977) Immunological status of mycetoma patients. Bull Soc Pathol Exot., 70, 48-54.
[17]	Beaman BL, Beaman L. Nocardia species: Host-parasite relationships. Clin Microbiol Rev. 1994; 7:48-54.
[18]	Beaman BL. Possible mechanisms of nocardial patho- genesis. In: Biology of the nocardiae pag 386-417. Ed Brownell G, Goodfellow M, Serrano JA. Academic Press London 1976.
[19]	Beaman BL, Black C. Interaction of Nocardia asteroides in BALB/c mice: Modulation of macrophage function, enzyme acvtivity and the induction of immunologically specific T-cell bactericidal activity. Curr Topics Microbiol. 1985; 122:138-147.
[20]	Castrillón RLE, Palma RA, Sampedro PGJ. Interacción de Actinomadura madurae con macrófagos peritoneales murinos. Rev Centro Dermatol Pascua. 1998; 7:37-43.
[21]	Palma RA, Cuevas MMV, Areanas GR, Vega MME, Castrillón RLE. Diseminación hematógena por Nocardia brasiliensis en tres ratones Balb/c a partir de un micetoma en cojinete plantar. Dermatol Rev Mex. 2008; 52:70-76.
[22]	López BAP, Arenas GA, Vega MME, Castrillón RLE, Palma RA. Identificación de células y mediadores in- flamatorios en lesiones de pacientes con diagnóstico de micetoma. Dermatol Rev Mex. 2008; 52:247-53.
[23]	Testi R, D’Ambrosio D, De Maria R, Santoni A. The CD69 receptor: a multipurpose cell-surface tigger for hematopoietic cells. Immunol Today. 1994; 15:479-483. doi:10.1016/0167-5699(94)90193-7
[24]	Garibay-Escobar, A., Estrada-García, I., Estrada-Parra, S., Santos-Argumedo, L. Integrated measurements by flow cytometry of the cytokines IL-2, IFN-γ, IL-12, TNF-α and functional evaluation of their receptors in human blood. J Immunol. Methods. 2003; 280:73-88. doi:10.1016/S0022-1759(03)00249-7
[25]	Collins, D. O. Cytokine and cytokine receptor expression as a biological indicator of immune activation: important considerations in the development of in vitro model sys- tems. J Immunol Methods. 2000; 243:125. doi:10.1016/S0022-1759(00)00218-0
[26]	Salinas-Carmona MC. Nocardia brasiliensis: from mi- crobe to human and experimental infections. Microbes and Infect. 2000; 2:1373-1381. doi:10.1016/S1286-4579(00)01291-0
[27]	Calcagno M. Status inmunológico del paciente con micetoma. Dermatol Ven 1989: 27:49-52.
[28]	Beaman BL, Scates SM. Role of L-forms of Nocardia caviae in the development of chronic mycetomas in nor- mal and immunodeficient murine models". Infect. Immun. 1981, 33 (3): 893-907.
[29]	Salinas-Carmona MC, Torres-López E, Ramos AI, Lincon-Trujillo González Spencer D. Immune response to Nocardia brasiliensis antigens in an experimental model in actinomicetoma in Balb/c mice. Infect Immun. 1999; 67:2428-2432.
[30]	Elson HL, Nutman BT, Metcalfe DDF, Prussin C. Flow cytometry analysis for cytokine production identifies T helper 1, T helper 2 and T helper 0 cells within the hu- man CD4 + CD27- lymnphocyte subpopulation. J Im- munol. 1995; 154:4294-4301.
[31]	Lucey RD, Clerici M,Shearer MG. Type 1 and Type 2 cytokine dysregulation in human infectious, neoplastic and inflammatory disease. Clin Microbiol Rev. 1996; 9:532-562.
[32]	Yamamura M, Uyemura K Deans RJ, Weinberg K, Rea TH, Bloom RB, Moldin RL. Defining protective reponses to pathogens: cytokine profiles in leprosy lesions. Sci- ence 1991; 254:277-279. doi:10.1126/science.1925582
[33]	El Hasssan AM, Fahal AH, Ahmed AO, Ismail A, Veress B. The immunopathology of actinomycetoma lesions caused by Streptomyces somaliensis. Trans R Soc Trop Hyg 2001; 95:89-92. doi:10.1016/S0035-9203(01)90346-3
[34]	Méndez-Tovar LJ, Mondragón-López R, Vega-López F, Dockrell MH, Hay R, López-Martínez R, Manzano- - Gayosso P, Hérnández-Hernández F, Padilla-Desgarennes C, Bonifaz A. Cytokine production and lymphocyte pro- liferation in patients with Nocardia brasiliensis actino- mycetoma. Mycopathologia 2004; 58:407-414.